致謝:本文經病原生物學博士雷娜 , 清華大學醫學院博士、美國Scripps研究所博士后研究員周盼盼專業審核
策劃:carollero|監制:gyouza
題圖來源:視覺中國
參考資料:
1.WorldHealthOrganization.XBB.1.5Rapidriskassessment.2023Jan11,2023[cited2023Jan12];Availablefrom:https://www.who.int/docs/default-source/coronaviruse/11jan2023_xbb15_rapid_risk_assessment.pdf.
2.Callaway,E.,CoronavirusvariantXBB.1.5risesintheUnitedStates-isitaglobalthreat?Nature,2023.613(7943):p.222-223.
3.CanYue,W.S.,LeiWang,FanchongJian,XiaosuChen,FeiGao,ZhongyangShen,YouchunWang,XiangxiWang,YunlongCao.EnhancedtransmissibilityofXBB.1.5iscontributedbybothstrongACE2bindingandantibodyevasion.2023Jan5,2023[cited2023Jan11];Availablefrom:https://www.biorxiv.org/content/10.1101/2023.01.03.522427v2.
4.Wang,Q.,S.Iketani,Z.Li,L.Liu,Y.Guo,Y.Huang,etal.,AlarmingantibodyevasionpropertiesofrisingSARS-CoV-2BQandXBBsubvariants.Cell,2022.
5.YueC,etal.EnhancedtransmissibilityofXBB.1.5iscontributedbybothstrongACE2bindingandantibodyevasion.bioRxiv;2023.
6.JingZou,C.K.,SohilPatel,NicholasKitchin,KristinTompkins,MarkCutler,DavidCooper,QiYang,HuiCai,AlexanderMuik,YingZhang,Dung-YangLee,UgurSahin,AnnaliesaS.Anderson,WilliamC.Gruber,XupingXie,KenaA.Swanson,Pei-YongShi.ImprovedNeutralizationofOmicronBA.4/5,BA.4.6,BA.2.75.2,BQ.1.1,andXBB.1withBivalentBA.4/5Vaccine.2022Nov17,2022[cited2023Jan11];Availablefrom:https://doi.org/10.1101/2022.11.17.516898.
7.WorldHealthOrganization.TAG-VEstatementonOmicronsublineagesBQ.1andXBB.2022Oct27,2022[cited2023Jan11];Availablefrom:https://www.who.int/news/item/27-10-2022-tag-ve-statement-on-omicron-sublineages-bq.1-and-xbb.
8.PulliamJRC,etal.IncreasedriskofSARS-CoV-2reinfectionassociatedwithemergenceofOmicroninSouthAfrica.Science.2022;376(6593):eabn4947.
9.CDC.COVIDDataTrackerWeeklyReview.2023Jan6,2023[cited2023Jan14];Availablefrom:https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html.
10.SingaporeMinistryofHealth.CorrectionsregardingXBBwaveinSingapore-FalsestatementsaboutCOVID-19situationinSingapore.2022Oct14,2022[cited2023Jan11];Availablefrom:https://www.gov.sg/article/factually141022-a.
11.SingaporeMinistryofHealth.UPDATEONCOVID-19SITUATIONANDMEASURESTOPROTECTHEALTHCARECAPACITY.2022Oct15,2022[cited2023Jan12];Availablefrom:https://www.moh.gov.sg/news-highlights/details/update-on-covid-19-situation-and-measures-to-protect-healthcare-capacity.
12.丁香醫生《XBB已進入中國 , 會造成新一輪感染高峰嗎?》
- 為什么中國這么短的時間內絕大多數人都已經陽過了呢?
- 第一波疫情已經徹底結束了,但是有個現象,細思極恐!
- 第一波疫情已經結束了,但有個現象,令人百思不得其解
- 數據顯示:已經有79種奧密克戎進化分支輸入到我國,其中比例比較高的前三位是…
- 第一批“陽”的人,已經產生了11種可怕的“后遺癥”,別不當回事
- 糖尿病患者一旦出現4類并發癥,可能我們的健康已經受到了威脅
- 五大抗衰老新技術帶來天量市場:諾華強生新基等企業已經在行動
- 咳嗽|腹瀉株XBB.1.5流行,蒙脫石散買不到不用擔心,中醫治療腹瀉有妙招
- 花生|發生心力衰竭,是否已經無藥可救?醫生:并非如此
- 如果出現下面6種現象,說明你已經二次感染了,建議多注意
